Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: A cautionary tale

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)S341-S345
JournalTranslational Andrology and Urology
Volume8
DOIs
StatePublished - 2019
Externally publishedYes

Bibliographical note

Funding Information:
Funding: This work was partially supported by National Institutes of Health Cancer Center Support Grant P30 CA006973 (PI: William Nelson), and Department of Defense grant W81XWH-16-PCRP-CCRSA.

Cite this